Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from infection, p, (left column) and mean vaccine efficacy, VEmean (right column). The proportion of cumulative infections averted (top row) and cumulative disease episodes averted (bottom row) were based on the number of each in the simulation without vaccination minus the number of each in the simulation with vaccination, both following 20 years of routine vaccination of 9-year olds at 80% coverage. Lines show the proportion of infections or diseases episodes averted as a function of each parameter varied on the x-axis, as estimated by a generalized additive model with independent smooth terms for each parameter. When one parameter is varied, the ...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
<p>Various fractions of the population (0%, 30%, 50%, and 70%) from 2 to 14 years old or from 2 to 4...
<p>The larger points represent the median attack rates (y-axis) of ten stochastic simulations run wh...
<p>Each plot shows the daily number of newly infected and symptomatic people from a single represent...
Bars display point estimates and 95% confidence intervals obtained from fitting generalized additive...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
<p>The yearly number of cases and hospitalizations per 100,000 individuals is estimated in 10-year s...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
<p>Various fractions of the population (0%, 30%, 50%, and 70%) from 2 to 14 years old or from 2 to 4...
<p>The larger points represent the median attack rates (y-axis) of ten stochastic simulations run wh...
<p>Each plot shows the daily number of newly infected and symptomatic people from a single represent...
Bars display point estimates and 95% confidence intervals obtained from fitting generalized additive...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
<p>The yearly number of cases and hospitalizations per 100,000 individuals is estimated in 10-year s...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidat...